INACTIVATED POLIO AND RABIES VACCINES MARKET ANALYSIS

Inactivated Polio And Rabies Vaccines Market, by Vaccine ( Inactivated Polio Vaccines and Inactivated Rabies Vaccines), By Method of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, and Others), By Age Group (Pediatrics and Adults), by Distribution Channel (Government and Private) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3581
Pages :179
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global Inactivated Polio And Rabies Vaccines Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global inactivated polio and rabies vaccines market over the forecast period. North America is estimated to hold 47.3% of the market share. The growing prevalence of Rabies disease and polio disease directly impacts the increased demand for the global inactivated polio and rabies vaccines market. For instance, on January 19, 2023, according to the World Health Organization, per year around, 35,172 human deaths and 21,476 human deaths occur due to rabies in North America. The cases of patients suffering from polio in Asia Pacific are reducing because of increasing awareness regarding the prevention of polio and rabies among the population and free immunization camps, which are organized by the government for immunizing the population against polio and rabies. Thus, North America is also projected to spur the global inactivated polio and rabies vaccines market growth over the forecast period.

North America: U.S. and Canada

Latin America: Brazil, Argentina, Mexico, and Rest of Latin America

Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe

Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific

Middle East: GCC Countries, Israel, and Rest of Middle East

Africa: South Africa, North Africa, and Central Africa